Plato Investment Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.73M Sell
12,435
-4,070
-25% -$1.13M 0.16% 146
2026
Q1
$4.88M Buy
16,505
+1,122
+7% +$333K 0.33% 68
2025
Q4
$4.22M Sell
15,383
-534
-3% -$145K 0.28% 78
2025
Q3
$4.27M Buy
15,917
+784
+5% +$213K 0.29% 81
2025
Q2
$4.16M Buy
15,133
+43
+0.3% +$11.7K 0.31% 72
2025
Q1
$4.05M Sell
15,090
-770
-5% -$190K 0.34% 73
2024
Q4
$3.7M Buy
15,860
+470
+3% +$108K 0.27% 87
2024
Q3
$3.39M Buy
15,390
+379
+3% +$78.4K 0.28% 88
2024
Q2
$2.95M Buy
15,011
+422
+3% +$87.2K 0.27% 85
2024
Q1
$3.14M Buy
14,589
+12,555
+617% +$2.64M 0.32% 79
2023
Q4
$428K Buy
+2,034
New +$434K 0.53% 44

Other funds holding CME

Plato Investment Management's CME Position: Q2 2026 in Review

Plato Investment Management reduced its CME Group (CME) stake by 25% in Q2 2026, selling an estimated $1.13M and leaving 12,435 shares worth $2.73M. The position accounts for 0.16% of the portfolio, ranked #146.

Plato Investment Management first reported a position in CME in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.88M in Q1 2026. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Plato Investment Management held 12,435 shares of CME Group worth $2.73M as of Q2 2026.
  • Plato Investment Management sold 4,070 CME Group shares in Q2 2026, an estimated $1.13M.
  • CME Group made up 0.16% of Plato Investment Management's portfolio in Q2 2026, its #146 holding.
  • Plato Investment Management first reported a position in CME Group in Q4 2023 and has held it in 11 quarters since.
  • Plato Investment Management's CME Group position peaked at $4.88M in Q1 2026.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.